One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Vaccine Contract Manufacturing Market

ワクチン受託製造市場:世界の見通しと予測(2021~2026年)


製品コード : ATHC00114826
調査 : Arizton
公開 : 14, June, 2022
カテゴリー : Healthcare and Pharmaceuticals
学習の場 : 北米(米国およびカナダ)、ラテンアメリカ(ブラジル、メキシコ、アルゼンチン、その他のラテンアメリカ)、ヨーロッパ(英国、ドイツ、フランス、イタリア、スペイン、ハンガリー、ベルギー、オランダおよびルクセンブルグ、NORDIC(フィンランド、スウェーデン、ノルウェー) 、デンマーク)、アイルランド、スイス、オーストリア、ポーランド、トルコ、ロシア、その他のヨーロッパ)、ポーランド、トルコ、ロシア、その他のヨーロッパ)、アジア太平洋(中国、インド、日本、韓国、シンガポール、インドネシア、マレーシア) 、オーストラリア、ニュージーランド、その他のアジア太平洋地域)、中東およびアフリカ(イスラエル、GCC(サウジアラビア、UAE、バーレーン、クウェート、カタール、オマーン)、北アフリカ、南アフリカ、その他の中東およびアフリカ)。
レポート形式 : PDF
販売価格オプション(消費税込み)
シングルユーザー USD3995 / 質問形式
法人ユーザー USD4500 / 質問形式
エンタープライズユーザー USD5500 / 質問形式

[レポートの説明]

COVID-19の影響に関する詳細な分析とデータ駆動型の洞察は、この世界のワクチン受託製造市場レポートに含まれています

世界のワクチン受託製造市場の収益別市場は、2020年から2026年の間に約13%のCAGRで成長すると予想されています.

世界のワクチン受託製造市場は、大規模な健康被害となったCOVID-19パンデミックの発生後、根本的な変化を経験しました。ワクチンCMOは、ウイルスが広範囲に広がり始めるにつれて大きな注目を集めています。COVID-19ウイルスの出現以来、ワクチンと生物学的医薬品開発の新しい時代が広がっています。世界的なパンデミックは、RNAベースのCOVIDワクチンの急速な加速により、ワクチンの革新を促進しました。受託製造会社は、世界中でCOVID-19ワクチンの入手可能性を高めるために取り組んでいます。

ワクチン製造のランドスケープは数十年にわたって劇的に変化しました。製薬会社とバイオテクノロジー企業のほぼ4分の3が、COVID-19ワクチンを開発するために契約メーカーと合併および契約を結んでいます。アウトソーシングは、エンドツーエンドの製造ソリューションやワクチン製造の専門知識などの大きな利点を提供するため、高い重要性を増しています。高水準の設備投資と製造の複雑さが相まって、新規参入が制限されています。ワクチン製品のパイプラインが成熟するにつれて、バイオテクノロジー企業は、既存の製造業者または委託製造業者と提携するか、社内の製造能力を開発するかの決定に直面しています

以下の要因が予測期間中のワクチン受託製造市場の成長に寄与する可能性が高い:
•グローバルCOVID-19ワクチン接種プログラム
• メーカーのスケールアップワクチン生産への注力
• ワクチン開発者と契約製造業者の間の合意の高まり
• ワクチンパイプラインが受託製造の需要を喚起

この調査では、世界のワクチン受託製造市場の現在のシナリオと、2020年から2026年までの市場ダイナミクスを検討しています。ここでは、いくつかの市場成長のイネーブラー、制約、トレンドの詳細な概要について説明します。このレポートは、市場の需要と供給の両方の側面を提供します。市場で事業を展開している大手企業やその他の著名な企業をプロファイルし、調査しています

世界のワクチン受託製造市場セグメンテーション

世界の商業用ワクチン受託製造市場は、2020年に64%以上を占めました。感染症の増加と世界的な風土病やパンデミックの発症により、受託製造サービスに対する高い需要がありました。北米は、ワクチンで予防可能な疾患による死亡を予防することへの関心が高まっているため、商業ワクチン市場に最大の収益をもたらすと予想しています。RNAプラットフォームの出現により、ワクチン開発プロセスが加速しました

臨床ワクチン受託製造市場は、予測期間中に4億9,200万米ドルを超える漸進的な成長を目撃すると予想されています。2019年の重症急性呼吸器症候群コロナウイルス2(SARS-CoV-2)の出現と、西アフリカと南部アフリカでのエボラ熱とラッサ熱の流行は、新興および再興感染症に対するワクチンと治療薬の緊急の必要性を示しています。いくつかの血清は、広範囲の伝染病とCOVID-19のパイプラインにあり、市場の成長を促進する可能性があります。前臨床セグメントは、2020年に世界のワクチン受託製造市場の13%のシェアを占めました。人口の増加、医療意識、新しい予防接種製品の需要、世界的な予防接種率の向上も、予防接種の必要性が世界的に高まっている要因の一部です

サブユニットワクチンは2020年に約34%の大きなシェアを占め、予測期間中に6億3,300万米ドルを超える最高の増分成長を目撃する可能性があります。主に多くの地域で予防接種率が低下しているため、風土病/パンデミックにつながる感染症が増加しているため、国内および国際機関は予防接種プログラムを厳格に実施し、より多くの人々が予防接種を受けることができます。これは、ワクチン生産の需要を高め、製造サービスにおけるCMOの専門知識に利益をもたらす可能性があります。組換えベクターCOVID-19ワクチンの受託製造サービス契約は高いです

フィル/フィニッシュサービス市場は、2020年から2026年の間に約13%のCAGRで成長すると予想されています。充填/仕上げサービスは、規制当局による極端な精査の対象となり、製造プロセスにおいてコストがかかる傾向があります。したがって、ワクチンメーカーはこれらのサービスをCMOにアウトソーシングし、CMOが予期しない需要、ソースポリシー、またはより良いマッチングスケールを満たすのに役立ちます。さらに、バイオ医薬品企業は、特殊な技術へのアクセスを得るために、充填と仕上げのニーズを外部委託しています。CMOは、バランスの取れた生産量と製造製品の商業的検証を満たすのに非常に役立ちます。したがって、バイオ医薬品の成長は、充填と仕上げの契約サービスの需要を刺激する可能性が高い

分析およびQC調査サービス市場は、2026年までに3億2,200万米ドルを超える漸進的な成長が見込まれています。メソッド開発とメソッド検証の両方を必要とする製品パイプライン製造の増加により、いくつかのバイオ医薬品企業が分析方法開発サービスを選択するようになりました。CMOは、メソッド開発、メソッド検証、製造サポート、リリーステスト、および安定性を実行します。したがって、分析およびQC研究サービスの需要は、バイオ製薬企業で成長すると予想されます

運用規模
•コマーシャル
• 臨床< / > • 前臨床

ワクチンの種類
• サブユニット
•ライブ減衰
• 非アクティブ化
• RNA
• その他< >
サービス
•充填/仕上げ
• 分析・QC研究
•セル/ウイルスバンキング
• その他< >
地理による洞察

北米には最も広範な受託製造組織があり、米国のいくつかの拠点に約40人のCMOが在籍しています。米国は、北米のワクチン受託製造市場シェアの90%以上を占めていました。アウトソーシングの増加傾向は、この地域の契約製造業者に利益をもたらしています。ワクチン製造に関連する規制、特に米国とカナダでは、市場の成長が加速しています。感染症の蔓延とワクチンで予防可能な疾患による死亡者数の増加により、製造の必要性が高まっています
欧州は、2020年のワクチン受託製造市場で26%と2番目に高いシェアを占めました。高齢者人口の増加、細菌およびウイルス感染の有病率、新しいワクチン接種の需要の増加、およびバイオ医薬品およびバイオテクノロジー産業の拡大は、欧州地域における受託製造の成長に寄与する主要な要因である。APACでは、主にワクチンへのアクセスを増やす人口の増加により、市場の需要が高まっています。APACでは、ワクチンパイプラインの成長、ワクチン製造サービスのアウトソーシングの増加、新規で革新的な技術の導入に関連するさまざまな機会が、ワクチン受託製造市場の将来に大きな影響を与えると予想されています

地理
• 北米< > o 米国< /> o カナダ< /> • ヨーロッパ
o イギリス< /> o ドイツ
o フランス< /> o イタリア< /> o スペイン< /> • APAC
o 中国
o インド< /> o 日本< /> o 韓国< /> o オーストラリア< /> • ラテンアメリカ
o メキシコ< /> o ブラジル< /> o アルゼンチン< /> • 中東・アフリカ
o サウジアラビア
o トルコ
o 南アフリカ

ベンダー別インサイト

味の素バイオファーマ、アルバニー分子研究所、キャタレント、サイトバンス・バイオロジクス、エマージェント・バイオソリューションズ、富士フイルム・ディオシンセ・バイオテクノロジーズ、グラクソ・スミスクラインは、世界のワクチン受託製造市場シェアを占める数社です。確立されたプレーヤーは、市場の競争力と浸透を高めるために戦略的提携と共同マーケティング契約を結んでいます。彼らはまた、生産のスケールアップのためにディストリビューターやサプライヤーと長期的な関係を築き、市場での地理的プレゼンスを拡大します。北米は大量の受託製造サービスを提供しています。ヨーロッパとAPACには、いくつかの著名なプレーヤーといくつかの中小規模のベンダーがいます。中国、インド、ブラジル、メキシコなどの新興経済国は、ベンダーに大きな成長機会を提供する可能性が高い。インドのワクチン受託製造会社は、インドの血清研究所とバーラトバイオテックの2つのバイオ医薬品会社も血清の緊急承認を受けているため、有望視されています

著名なベンダー
• 味の素バイオファーマ
• アルバニー分子研究(AMRI)
• キャタレント< /> • サイトバンス生物製剤
• Emergent BioSolutions
• 富士フイルム
• グラクソ・スミスクライン
• IDT Biologika
• ロンザ<ブラ/> • メルク KGaA
• ファイザー
• レシピファム
• インド血清研究所
• ジークフリート・ホールディング

その他の著名なベンダー
• コブラ・バイオロジクス
• バクスターバイオファーマソリューションズ
• グッドウィン・バイオテクノロジー
• KBIバイオファーマ
• サノフィ<ブル/> • BioMARC
• バイエルン北欧
• チャールズリバー研究所
• ベーリンガーインゲルハイム
•サムスン生物製剤
•メリディアンライフサイエンス
•ワッカーバイオテックB.V.
•歓喜のホリスターシュティエ
• アッビー<ブラ/> • ノヴァセップ
• ケムウェルバイオファーマ
• ノースウェイバイオテク< /> • ミダスファーマ
• アルカミ
• カンブレックス
• アシンケム
• Pharmaceutics International Inc. (Pii)
•シャープ<ブラル/> • シンゴタソリューションズ
• サーモフィッシャーサイエンティフィック
• カネカ・ユーロジェンテック
• Richter-Helm BioLogics
•オロジーバイオサービス
•コーデンファーマ
•セルビオスファーマ
• BSPファーマシューティカルズ
• JOINN Biologics
•ユーロフィンサイエンティフィック
• プロバイオジェン
•エスコアスター<ブラ/> • ジェノビオールバイオテクノロジー
• AGCバイオロジクス
• EirGenix
• アマランバイオテク
•エデン生物製剤
• アブゼナ<ブル/> • アルデブロン
• 細胞培養会社
• タロンソリューションズ
• MabPlex
• アクセレレート製薬
• 無錫生物製剤
•テラピュアバイオファーマ

主な質問の回答:
1. ワクチン受託製造市場はどのくらいの大きさですか?
2. 予測期間中に最大の収益を生み出す可能性が高いのはどのセグメントか?
3. ワクチンメーカーの数が最も多い地域はどこですか?
4. トップワクチンメーカーは誰ですか?
5. COVID-19のパンデミックは受託製造会社にどのような影響を与えましたか?
6. CMOへのCOVID-19ワクチンの供給にはどのような制限がありますか?

List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 WHO recommendations for priority use of COVID-19 vaccine during limited supply
Table 4 Current Vaccine Pipeline for Infectious Diseases
Table 5 Vaccines for Various Infectious and Cancer Diseases in Clinical Trials
Table 6 New Vaccine Candidates for Tuberculosis in Preclinical Phase in 2020
Table 7 Types of vaccines available for various infectious diseases
Table 8 Vaccine Contract Manufacturing Market in North America by Scale of Operations 2020−2026 ($ million)
Table 9 Vaccine Contract Manufacturing Market in North America by Scale of Operations 2020−2026 (%)
Table 10 Vaccine Contract Manufacturing Market in North America by Vaccine type 2020−2026 ($ million)
Table 11 Vaccine Contract Manufacturing Market in North America by Vaccine Type 2020−2026 (%)
Table 12 Vaccine Contract Manufacturing Market in North America by Service 2020−2026 ($ million)
Table 13 Vaccine Contract Manufacturing Market in North America by Service 2020−2026 (%)
Table 14 Vaccine Contract Manufacturing Market in Europe by Scale of Operations 2020−2026 ($ million)
Table 15 Vaccine Contract Manufacturing Market in Europe by Scale of Operations 2020−2026 (%)
Table 16 Vaccine Contract Manufacturing Market in Europe by Vaccine type 2020−2026 ($ million)
Table 17 Vaccine Contract Manufacturing Market in Europe by Vaccine type 2020−2026 (%)
Table 18 Vaccine Contract Manufacturing Market in Europe by Service 2020−2026 ($ million)
Table 19 Vaccine Contract Manufacturing Market in Europe by Service 2020−2026 (%)
Table 20 Vaccine Contract Manufacturing Market in APAC by Scale of Operations 2020−2026 ($ million)
Table 21 Vaccine Contract Manufacturing Market in APAC by Scale of Operations 2020−2026 (%)
Table 22 Vaccine Contract Manufacturing Market in APAC by Vaccine Type 2020−2026 ($ million)
Table 23 Vaccine Contract Manufacturing Market in APAC by Vaccine Type 2020−2026 (%)
Table 24 Vaccine Contract Manufacturing Market in APAC by Service 2020−2026 ($ million)
Table 25 Vaccine Contract Manufacturing Market in APAC by Service 2020−2026 (%)
Table 26 Vaccine Contract Manufacturing Market in Latin America by Scale of Operations 2020−2026 ($ million)
Table 27 Vaccine Contract Manufacturing Market in Latin America by Scale of Operations 2020−2026 (%)
Table 28 Vaccine Contract Manufacturing Market in Latin America by Vaccine Type 2020−2026 ($ million)
Table 29 Vaccine Contract Manufacturing Market in Latin America by Vaccine Type 2020−2026 (%)
Table 30 Vaccine Contract Manufacturing Market in Latin America by Service 2020−2026 ($ million)
Table 31 Vaccine Contract Manufacturing Market in Latin America by Service 2020−2026 (%)
Table 32 Vaccine Contract Manufacturing Market in the Middle East & Africa by Scale of Operations 2020−2026 ($ million)
Table 33 Vaccine Contract Manufacturing Market in the Middle East & Africa by Scale of Operations 2020−2026 (%)
Table 34 Vaccine Contract Manufacturing Market in the Middle East & Africa by Vaccine Type 2020−2026 ($ million)
Table 35 Vaccine Contract Manufacturing Market in the Middle East & Africa by Vaccine Type 2020−2026 (%)
Table 36 Vaccine Contract Manufacturing Market in the Middle East & Africa by Service 2020−2026 ($ million)
Table 37 Vaccine Contract Manufacturing Market in the Middle East & Africa by Service 2020−2026 (%)
Table 38 Ajinomoto: Major Service Offerings
Table 39 Albany Molecular Research: Major Service Offerings
Table 40 Catalent: Major Service Offerings
Table 41 Cytovance Biologics: Major Service Offerings
Table 42 Emergent BioSolutions: Major Service Offerings
Table 43 FUJIFILM: Major Service Offerings
Table 44 GSK: Major Service Offerings
Table 45 IDT Biologika: Major Service Offerings
Table 46 Lonza: Major Service Offerings
Table 47 Merck: Major Service Offerings
Table 48 Pfizer: Major Service Offerings
Table 49 Recipharm: Major Service Offerings
Table 50 Serum Institute of India: Major Service Offerings
Table 51 Siegfried: Major Service Offerings
Table 52 Cobra Biologics: Major Service Offerings
Table 53 Baxter Healthcare: Major Service Offerings
Table 54 Goodwin Biotechnology: Major Service Offerings
Table 55 KBI Biopharma: Major Service Offerings
Table 56 Sanofi: Major Service Offerings
Table 57 BioMARC: Major Service Offerings
Table 58 Bavarian Nordic: Major Service Offerings
Table 59 Charles River Laboratories: Major Service Offerings
Table 60 Boehringer Ingelheim: Major Service Offerings
Table 61 Samsung Biologics: Major Service Offerings
Table 62 Meridian Life Science: Major Service Offerings
Table 63 Wacker Biotech B.V: Major Service Offerings
Table 64 Jubilant HollisterStier: Major Service Offerings
Table 65 AbbVie: Major Service Offerings
Table 66 Novasep: Major Service Offerings
Table 67 Kemwell Biopharma: Major Service Offerings
Table 68 Northway Biotech: Major Service Offerings
Table 69 Midas Pharma: Major Service Offerings
Table 70 Alcami: Major Service Offerings
Table 71 Cambrex: Major Service Offerings
Table 72 Asymchem: Major Service Offerings
Table 73 Pharmaceutics International: Major Service Offerings
Table 74 Sharp: Major Service Offerings
Table 75 Singota Solutions: Major Service Offerings
Table 76 Thermo Fisher Scientific: Major Service Offerings
Table 77 Kaneka Eurogentec: Major Service Offerings
Table 78 Richter-Helm BioLogics: Major Service Offerings
Table 79 Ology Bioservices: Major Service Offerings
Table 80 Corden Pharma: Major Service Offerings
Table 81 Cerbios Pharma: Major Service Offerings
Table 82 BSP Pharmaceuticals: Major Service Offerings
Table 83 JOINN Biologics: Major Service Offerings
Table 84 Eurofins Scientific: Major Service Offerings
Table 85 ProBioGen: Major Service Offerings
Table 86 Esco Aster: Major Service Offerings
Table 87 Genovior Biotech: Major Service Offerings
Table 88 AGC Biologics: Major Service Offerings
Table 89 EirGenix: Major Service Offerings
Table 90 Amaran Biotech: Major Service Offerings
Table 91 Eden Biologics: Major Service Offerings
Table 92 Abzena: Major Service Offerings
Table 93 Aldevron: Major Service Offerings
Table 94 Cell Culture Company: Major Service Offerings
Table 95 Taron Solutions: Major Service Offerings
Table 96 MabPlex: Major Service Offerings
Table 97 Axcellerate Pharma: Major Service Offerings
Table 98 WuXi Biologics: Major Service Offerings
Table 99 Therapure Biopharma: Major Service Offerings
Table 100 Global Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 ($ million)
Table 101 Global Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 (%)
Table 102 North America Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 ($ million)
Table 103 North America Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 (%)
Table 104 Europe Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 ($ million)
Table 105 Europe Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 (%)
Table 106 APAC Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 ($ million)
Table 107 APAC Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 (%)
Table 108 Latin America Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 ($ million)
Table 109 Latin America Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 (%)
Table 110 Middle East & Africa Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 ($ million)
Table 111 Middle East & Africa Vaccine Contract Manufacturing Market by Scale of Operations 2020−2026 (%)
Table 112 Global Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 ($ million)
Table 113 Global Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 (%)
Table 114 North America Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 ($ million)
Table 115 North America Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 (%)
Table 116 Europe Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 ($ million)
Table 117 Europe Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 (%)
Table 118 APAC Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 ($ million)
Table 119 APAC Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 (%)
Table 120 Latin America Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 ($ million)
Table 121 Latin America Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 (%)
Table 122 Middle East & Africa Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 ($ million)
Table 123 Middle East & Africa Vaccine Contract Manufacturing Market by Vaccine type 2020−2026 (%)
Table 124 Global Vaccine Contract Manufacturing Market by Service 2020−2026 ($ million)
Table 125 Global Vaccine Contract Manufacturing Market by Service 2020−2026 (%)
Table 126 North America Vaccine Contract Manufacturing Market by Service 2020−2026 ($ million)
Table 127 North America Vaccine Contract Manufacturing Market by Service 2020−2026 (%)
Table 128 Europe Vaccine Contract Manufacturing Market by Service 2020−2026 ($ million)
Table 129 Europe Vaccine Contract Manufacturing Market by Service 2020−2026 (%)
Table 130 APAC Vaccine Contract Manufacturing Market by Service 2020−2026 ($ million)
Table 131 APAC Vaccine Contract Manufacturing Market by Service 2020−2026 (%)
Table 132 Latin America Vaccine Contract Manufacturing Market by Service 2020−2026 ($ million)
Table 133 Latin America Vaccine Contract Manufacturing Market by Service 2020−2026 (%)
Table 134 Middle East & Africa Vaccine Contract Manufacturing Market by Service 2020−2026 ($ million)
Table 135 Middle East & Africa Vaccine Contract Manufacturing Market by Service 2020−2026 (%)
Table 136 Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 137 Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 138 Commercial Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 139 Commercial Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 140 Clinical Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 141 Clinical Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 142 Preclinical Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 143 Preclinical Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 144 Sub-unit Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 145 Sub-unit Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 146 Live-attenuated Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 147 Live-attenuated Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 148 Inactivated Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 149 Inactivated Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 150 RNA Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 151 RNA Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 152 Others Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 153 Others Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 154 Fill/Finish Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 155 Fill/Finish Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 156 Analytical & QC Studies Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 157 Analytical & QC Studies Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 158 Cell/Virus banking Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 159 Cell/Virus banking Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)
Table 160 Others Vaccine Contract Manufacturing Market by Geography 2020−2026 ($ million)
Table 161 Others Vaccine Contract Manufacturing Market by Geography 2020−2026 (%)

List of Exhibits
Exhibit 1 Segmentation of Global Vaccine Contract Manufacturing Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Factors Considered Before a Partnership with Contract Manufacturers
Exhibit 4 Opportunities for Contract Manufacturers
Exhibit 5 Impact of Global Vaccination Programs for COVID-19
Exhibit 6 Impact of Manufacturers’ Focus on Scale-Up Vaccine Production
Exhibit 7 Impact of Growing Agreements Between Vaccine Developers and Contract Manufacturers
Exhibit 8 Vaccine Production Outsourcers from Buyer Groups
Exhibit 9 Impact of Vaccine Pipeline Boosting the Demand for Contract Manufacturing
Exhibit 10 Vaccines in the Pipeline for Various Infectious Diseases
Exhibit 11 DCVMN Pipeline: Number of Vaccine Projects in Development (2019)
Exhibit 12 Impact of Favorable Patient Demographics & Growing Vaccinations of Newborns and Children
Exhibit 13 Disease Incidence in the World 2020 (million)
Exhibit 14 Global Vaccination Coverage of 1-year-olds in 2019
Exhibit 15 Eradication of Major Diseases Through Vaccines in US
Exhibit 16 Impact of Effect of Epidemics & Pandemics on Vaccine Development
Exhibit 17 Number of Epidemic Events During 2011-2017
Exhibit 18 Impact of Cost-Effective and Time-Saving Services of Contract Manufacturers
Exhibit 19 Major Advantages of Engaging with CMOs
Exhibit 20 Impact of High Costs and Stockout Issues of Vaccines
Exhibit 21 Reported Stockouts of Vaccines During 2010-2018
Exhibit 22 Impact of Lack of Storage Infrastructure & Limitations Associated with Supply Chain
Exhibit 23 Major Barriers to Effective Vaccine Handling and Storage
Exhibit 24 Impact of Vaccination Concerns in Low- and Middle-Income Countries
Exhibit 25 Ten Most Frequently Reported Vaccination Concerns in LMICs
Exhibit 26 Global Vaccine Contract Manufacturing Market 2020–2026 ($ million)
Exhibit 27 Global Vaccine Contract Manufacturing Market by Scale of Operations
Exhibit 28 Global Vaccine Contract Manufacturing Market by Geography
Exhibit 29 Global Vaccine Contract Manufacturing Market by Vaccine type
Exhibit 30 Global Vaccine Contract Manufacturing Market by Service
Exhibit 31 Five Forces Analysis 2020
Exhibit 32 Incremental Growth by Scale of Operations 2020 & 2026
Exhibit 33 Global Vaccine Contract Manufacturing Market by Scale of Operations
Exhibit 34 Vaccine Pipeline for Various Infectious Diseases 2020
Exhibit 35 COVID-19 Vaccine Candidates in Various Clinical Stages of Development
Exhibit 36 Global Vaccine Contract Manufacturing Market by Scale of Operations: Incremental Growth
Exhibit 37 Global Vaccine Contract Manufacturing Market by Scale of Operations: Absolute Growth
Exhibit 38 Global Vaccine Contract Manufacturing Market by Commercial Segment: Incremental & Absolute Growth
Exhibit 39 Vaccines in the Pipeline for Various Diseases in 2020
Exhibit 40 Vaccines in the Pipeline by Disease Type in 2020
Exhibit 41 Global Vaccine Contract Manufacturing Market by Commercial Segment 2020–2026 ($ million)
Exhibit 42 Incremental Growth by Geography 2020 & 2026
Exhibit 43 Global Vaccine Contract Manufacturing Market by Clinical Segment: Incremental & Absolute Growth
Exhibit 44 Global Vaccine Contract Manufacturing Market by Clinical Segment 2020–2026 ($ million)
Exhibit 45 Incremental Growth by Geography 2020 & 2026
Exhibit 46 Global Vaccine Contract Manufacturing Market by Preclinical Segment: Incremental & Absolute Growth
Exhibit 47 Global Vaccine Contract Manufacturing Market by Preclinical Segment 2020–2026 ($ million)
Exhibit 48 Incremental Growth by Geography 2020 & 2026
Exhibit 49 Incremental Growth by Vaccine Type 2020 & 2026
Exhibit 50 Global Vaccine Contract Manufacturing Market by Vaccine Type
Exhibit 51 Different Types of COVID-19 Vaccines Under Research by 2020
Exhibit 52 Global Vaccine Contract Manufacturing Market by Vaccine Type: Incremental Growth
Exhibit 53 Global Vaccine Contract Manufacturing Market by Vaccine Type: Absolute Growth
Exhibit 54 Global Vaccine Contract Manufacturing Market by Sub-Unit Vaccines: Incremental & Absolute Growth
Exhibit 55 Global Vaccine Contract Manufacturing Market by Sub-Unit Vaccines 2020–2026 ($ million)
Exhibit 56 Incremental Growth by Geography 2020 & 2026
Exhibit 57 Global Vaccine Contract Manufacturing Market by Live-Attenuated Vaccines: Incremental & Absolute Growth
Exhibit 58 Global Vaccine Contract Manufacturing Market by Live-Attenuated Vaccines 2020–2026 ($ million)
Exhibit 59 Incremental Growth by Geography 2020 & 2026
Exhibit 60 Global Vaccine Contract Manufacturing Market by Inactivated Vaccines: Incremental & Absolute Growth
Exhibit 61 Global Vaccine Contract Manufacturing Market by Inactivated Vaccines 2020–2026 ($ million)
Exhibit 62 Incremental Growth by Geography 2020 & 2026
Exhibit 63 Global Vaccine Contract Manufacturing Market by RNA Vaccines: Incremental & Absolute Growth
Exhibit 64 Global Vaccine Contract Manufacturing Market by RNA Vaccines 2020–2026 ($ million)
Exhibit 65 Incremental Growth by Geography 2020 & 2026
Exhibit 66 Global Vaccine Contract Manufacturing Market by Others: Incremental & Absolute Growth
Exhibit 67 Global Vaccine Contract Manufacturing Market by Others 2020–2026 ($ million)
Exhibit 68 Incremental Growth by Geography 2020 & 2026
Exhibit 69 Incremental Growth by Service 2020 & 2026
Exhibit 70 Global Vaccine Contract Manufacturing Market by Service
Exhibit 71 Major Biopharmaceutical Contract Manufacturing Services
Exhibit 72 Global Vaccine Contract Manufacturing Market by Service: Incremental Growth
Exhibit 73 Global Vaccine Contract Manufacturing Market by Service: Absolute Growth
Exhibit 74 Global Vaccine Contract Manufacturing Market by Fill/Finish: Incremental & Absolute Growth
Exhibit 75 Outsourcing Fill-And-Finish Services to CMOs
Exhibit 76 Global Vaccine Contract Manufacturing Market by Fill/Finish Services 2020–2026 ($ million)
Exhibit 77 Incremental Growth by Geography 2020 & 2026
Exhibit 78 Analytical and QC Services Outsourced by Biopharma Manufacturers
Exhibit 79 Global Vaccine Contract Manufacturing Market by Analytical & QC Studies: Incremental & Absolute Growth
Exhibit 80 Global Vaccine Contract Manufacturing Market by Analytical & QC Studies 2020–2026 ($ million)
Exhibit 81 Incremental Growth by Geography 2020 & 2026
Exhibit 82 Protein Expression Systems Offered by Top CMOs
Exhibit 83 Global Vaccine Contract Manufacturing Market by Cell/Virus Banking: Incremental & Absolute Growth
Exhibit 84 Global Vaccine Contract Manufacturing Market by Cell/Virus Banking 2020–2026 ($ million)
Exhibit 85 Incremental Growth by Geography 2020 & 2026
Exhibit 86 Global Vaccine Contract Manufacturing Market by Others: Incremental & Absolute Growth
Exhibit 87 Biopharma Companies Outsourcing Their Regulatory Requirements
Exhibit 88 Global Vaccine Contract Manufacturing Market by Others 2020–2026 ($ million)
Exhibit 89 Incremental Growth by Geography 2020 & 2026
Exhibit 90 Incremental Growth by Geography 2020 & 2026
Exhibit 91 Global Vaccine Contract Manufacturing Market by Geography
Exhibit 92 Global Vaccine Contract Manufacturing Market by Geography: Key Countries ($ million)
Exhibit 93 Global Vaccine Contract Manufacturing Market by Geography: Incremental Growth
Exhibit 94 Global Vaccine Contract Manufacturing Market by Geography: Absolute Growth
Exhibit 95 Market Share of Major Countries in North America
Exhibit 96 Deaths Caused by Vaccine-Preventable Diseases in North America (2013-2017)
Exhibit 97 Vaccine Contract Manufacturing Market in North America: Key Countries 2020
Exhibit 98 Vaccine Contract Manufacturing Market in North America: Incremental & Absolute Growth
Exhibit 99 Vaccine Contract Manufacturing Market in North America 2020–2026 ($ million)
Exhibit 100 Incremental Growth by Scale of Operations 2020 & 2026
Exhibit 101 Incremental Growth by Vaccine Type 2020 & 2026
Exhibit 102 Incremental Growth by Service 2020 & 2026
Exhibit 103 Incremental Growth in North America 2020 & 2026
Exhibit 104 Major Infectious Diseases Causing Deaths in the US
Exhibit 105 Vaccine Contract Manufacturing Market in the US 2020–2026 ($ million)
Exhibit 106 Number of Deaths Caused by Major Infectious Diseases in Canada
Exhibit 107 Vaccination Coverage in Children Aged 1 Year in Canada
Exhibit 108 Vaccine Contract Manufacturing Market in Canada 2020–2026 ($ million)
Exhibit 109 Market Share of Major Countries in Europe
Exhibit 110 Burden of Vaccine-Preventable Diseases in Europe 2009–2013
Exhibit 111 Vaccine Contract Manufacturing Market in Europe: Key Countries 2020
Exhibit 112 Vaccine Contract Manufacturing Market in Europe: Incremental & Absolute Growth
Exhibit 113 Vaccine Contract Manufacturing Market in Europe 2020–2026 ($ million)
Exhibit 114 Incremental Growth by Scale of Operations 2020 & 2026
Exhibit 115 Incremental Growth by Vaccine Type 2020 & 2026
Exhibit 116 Incremental Growth by Service 2020 & 2026
Exhibit 117 Incremental Growth in Europe 2020 & 2026
Exhibit 118 Deaths Caused by Vaccine-Preventable Diseases in Germany
Exhibit 119 Vaccine Contract Manufacturing Market in Germany 2020–2026 ($ million)
Exhibit 120 Vaccine-Preventable Diseases Causing Deaths in the UK
Exhibit 121 Vaccine Contract Manufacturing Market in the UK 2020–2026 ($ million)
Exhibit 122 Major Infectious Diseases Causing Deaths in France
Exhibit 123 Target Population Immunized for Vaccine-Preventable Diseases
Exhibit 124 Vaccine Contract Manufacturing Market in France 2020–2026 ($ million)
Exhibit 125 Deaths due to Vaccine-Preventable Diseases in Italy
Exhibit 126 Vaccine Contract Manufacturing Market in Italy 2020–2026 ($ million)
Exhibit 127 Major Vaccine-Preventable Diseases Causing Deaths in Spain
Exhibit 128 Vaccine Contract Manufacturing Market in Spain 2020–2026 ($ million)
Exhibit 129 Market Share of Major Countries in APAC
Exhibit 130 Vaccine Contract Manufacturing Market in APAC: Key Countries 2020
Exhibit 131 Vaccine Contract Manufacturing Market in APAC: Incremental & Absolute Growth
Exhibit 132 Vaccine Contract Manufacturing Market in APAC 2020–2026 ($ million)
Exhibit 133 Incremental Growth by Scale of Operations 2020 & 2026
Exhibit 134 Incremental Growth by Vaccine Type 2020 & 2026
Exhibit 135 Incremental Growth by Service 2020 & 2026
Exhibit 136 Incremental Growth in APAC 2020 & 2026
Exhibit 137 Major Vaccine-Preventable Diseases Causing Deaths in China
Exhibit 138 Vaccine Contract Manufacturing Market in China 2020–2026 ($ million)
Exhibit 139 Major Infectious Diseases Causing Mortality in India
Exhibit 140 Vaccine Contract Manufacturing Market in India 2020–2026 ($ million)
Exhibit 141 Deaths Caused due to Various Infectious Diseases in Japan
Exhibit 142 Vaccine Contract Manufacturing Market in Japan 2020–2026 ($ million)
Exhibit 143 Deaths due to Vaccine-Preventable Diseases in South Korea
Exhibit 144 Vaccine Contract Manufacturing Market in South Korea 2020–2026 ($ million)
Exhibit 145 Deaths Caused by Infectious Diseases in Australia
Exhibit 146 Vaccine Contract Manufacturing Market in Australia 2020–2026 ($ million)
Exhibit 147 Market share of major countries in Latin America
Exhibit 148 Deaths Caused by Vaccine-Preventable Diseases
Exhibit 149 Vaccine Contract Manufacturing Market in Latin America: Key Countries 2020
Exhibit 150 Vaccine Contract Manufacturing Market in Latin America: Incremental & Absolute Growth
Exhibit 151 Vaccine Contract Manufacturing Market in Latin America 2020–2026 ($ million)
Exhibit 152 Incremental Growth by Scale of Operations 2020 & 2026
Exhibit 153 Incremental Growth by Vaccine Type 2020 & 2026
Exhibit 154 Incremental Growth by Service 2020 & 2026
Exhibit 155 Incremental Growth in Latin America 2020 & 2026
Exhibit 156 Major Deaths Caused due to Vaccine-Preventable Diseases
Exhibit 157 National Immunization Coverage for Brazil (%)
Exhibit 158 Vaccine Contract Manufacturing Market in Brazil 2020–2026 ($ million)
Exhibit 159 Deaths Caused by Vaccine-Preventable Diseases
Exhibit 160 Vaccine Contract Manufacturing Market in Mexico 2020–2026 ($ million)
Exhibit 161 Deaths Caused due to Vaccine-Preventable Diseases
Exhibit 162 Vaccine Contract Manufacturing Market in Argentina 2020–2026 ($ million)
Exhibit 163 Market Share of Major Countries in the Middle East & Africa
Exhibit 164 Vaccine-Preventable Diseases Causing Mortality in the Middle East & Africa
Exhibit 165 Vaccine Contract Manufacturing Market in the Middle East & Africa: Key Countries 2020
Exhibit 166 Vaccine Contract Manufacturing Market in the Middle East & Africa: Incremental & Absolute Growth
Exhibit 167 Vaccine Contract Manufacturing Market in the Middle East & Africa 2020–2026 ($ million)
Exhibit 168 Incremental Growth by Scale of Operations 2020 & 2026
Exhibit 169 Incremental Growth by Vaccine Type 2020 & 2026
Exhibit 170 Incremental Growth by Service 2020 & 2026
Exhibit 171 Incremental Growth in the Middle East & Africa 2020 & 2026
Exhibit 172 Deaths Caused by Vaccine-Preventable Diseases
Exhibit 173 Target Population Immunized for Vaccine-Preventable Diseases
Exhibit 174 Vaccine Contract Manufacturing Market in South Africa 2020–2026 ($ million)
Exhibit 175 Deaths Caused by Vaccine-Preventable Diseases
Exhibit 176 Vaccine Contract Manufacturing Market in Saudi Arabia 2020–2026 ($ million)
Exhibit 177 Deaths due to Vaccine-Preventable Diseases in Turkey
Exhibit 178 Vaccine Contract Manufacturing Market in Turkey 2020–2026 ($ million)
Exhibit 179 Ajinomoto: Revenue 2017-2019 ($ billion)
Exhibit 180 Ajinomoto: Revenue by Segments 2018-2019 ($ billion)
Exhibit 181 Ajinomoto: Revenue Share by Geographical Region 2019 ($ billion)
Exhibit 182 Catalent: Revenue 2018-2020 ($ million)
Exhibit 183 Catalent: Revenue Share by Geographical Region 2020 & 2019 ($ million)
Exhibit 184 Emergent BioSolutions: Revenue 2018-2020 ($ million)
Exhibit 185 Emergent BioSolutions: Revenue by Segments 2019-2020 ($ million)
Exhibit 186 FUJIFILM: Revenue 2017-2019 ($ billion)
Exhibit 187 FUJIFILM: Revenue by Segments 2018-2019 ($ billion)
Exhibit 188 GSK: Revenue 2017-2020 ($ billion)
Exhibit 189 GSK: Revenue by Segments 2018-2019 ($ billion)
Exhibit 190 GSK: R&D Expenditure During 2018-2019 ($ million)
Exhibit 191 GSK: Revenue Share by Geographical Region During 2018-2019 ($ million)
Exhibit 192 Lonza: Revenue 2018-2019 ($ million)
Exhibit 193 Lonza: Revenue by Segments 2018-2019 ($ million)
Exhibit 194 Lonza: Revenue Share by Geographical Region 2019 ($ million)
Exhibit 195 Merck KGaA: Revenue Share During 2017-2020 ($ billion)
Exhibit 196 Pfizer: Revenue Share 2017-2019 ($ million)
Exhibit 197 Pfizer: Revenue by Segments 2018-2019 ($ million)
Exhibit 198 Pfizer: R&D Expenditure 2017-2019 ($ million)
Exhibit 199 Pfizer: Revenue Share by Geographical Region During 2018-2019 ($ million)
Exhibit 200 Recipharm: Revenue share 2017-2019 ($ million)
Exhibit 201 Recipharm: Revenue Share by Segments 2018-2019 ($ million)
Exhibit 202 Recipharm: Revenue Share by Geography 2018-2019 ($ million)
Exhibit 203 Siegfried: Revenue 2018-2020 ($ million)

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+